Introduction
cancer, coronavirus disease 2019
CANCER, CORONAVIRUS DISEASE 2019, HEMATOLOGIC MALIGNANCIES
It is now well established that coronavirus disease 2019 (COVID-19) in patients with cancer carries a higher morbidity and mortality, especially in patients with hematologic malignancies (We previously published preliminary results of a study defining notable impacts of a third dose of vaccine, demonstrating a more than 50% seroconversion rate among patients remaining seronegative after primary vaccination series of two mRNA vaccine or one adenoviral vaccine (